Pulse in Japan: Building Bridges at 3one4 Emergent Japan
In October 2026, Pulse travelled to Japan at the invitation of 3one4 Capital, the investor that led Pulse's seed round. Here is what the Emergent programme is and what it meant for Pulse.
In October 2026, Pulse co-founder Anshul Sharma represented Pulse at 3one4 Emergent Japan, a programme run by 3one4 Capital, the venture fund that led Pulse's $4 million seed round. Emergent brings selected 3one4 founders together with Japanese companies, banks and investors for presentations and one-to-one meetings.
What Is 3one4 Emergent?
Emergent is 3one4 Capital's programme for connecting its portfolio founders with leading institutions, investors and markets abroad. It is a working trip of meetings and presentations rather than a conference where founders sit and listen. Earlier editions were held in Singapore, Japan and Mumbai.
The Japan editions show what the programme does. In 2024, founders took part in 118 meetings with 53 Japanese corporations, investors and fund partners over four days, with a showcase day at Mizuho Bank's headquarters in Tokyo. In 2025, Emergent Tokyo held more than 120 meetings across 53 institutions, again hosted at Mizuho Bank.
Pulse at Emergent Japan
Pulse co-founder Anshul Sharma represented the company. He presented the Pulse story to the room and joined founders, investors and Japanese industry leaders for a day of ideas and introductions.
As Pulse wrote afterwards: "Meaningful innovation happens when ambitious ideas meet the right people, perspectives, and opportunities."
Need a price for your hospital or clinic?Get a written quote, brochure or demo from the Pulse team.
Why Japan Matters for Pulse
- Quality standards. Japan is known for precision engineering, careful manufacturing and strict quality, which matter most in medical equipment.
- Partners looking at India. Japanese companies are looking for growth and new supply partners outside their home market, and India is high on that list.
- Technology and parts. Links with Japanese firms can help Pulse bring better technology and components into equipment made with Indian partners.
About 3one4 Capital and Pulse
3one4 Capital is a Bengaluru-based venture capital firm. It led Pulse's $4 million seed round, with Incubate Fund Asia and Stride Ventures taking part. Read the full story: Pulse raises $4 million in a round led by 3one4 Capital.
Earlier in 2026, the Pulse team also exhibited at WHX Dubai and MedExpo Africa in Nairobi.
Key Facts at a Glance
- Emergent is 3one4 Capital's programme connecting its founders with institutions in other markets.
- Pulse co-founder Anshul Sharma represented Pulse at Emergent Japan in October 2026.
- Earlier Japan editions: 118 meetings with 53 organisations (2024) and 120+ meetings across 53 institutions (2025).
- 3one4 Capital led Pulse's $4 million seed round.
Pulse in Japan: FAQs
What is 3one4 Emergent Japan?
It is part of 3one4 Capital's Emergent programme, which takes selected portfolio founders to meet Japanese companies, banks and investors through presentations and one-to-one meetings.
Who represented Pulse at Emergent Japan?
Pulse co-founder Anshul Sharma represented Pulse at 3one4 Emergent Japan in October 2026.
Why was Pulse invited by 3one4 Capital?
3one4 Capital is Pulse's investor; it led Pulse's $4 million seed round. Emergent is open to selected founders from its portfolio.
Why does Japan matter for an Indian medtech company?
Japan is known for precision engineering and strict quality standards, and Japanese companies are looking for partners in India, which can help with technology, components and quality.
Sources
- 3one4 Capital's Emergent Japan 2024: Building the Indo-Japan Innovation Corridor (3one4 Capital, July 2024)
- Emergent Tokyo 2025: A New Chapter in the India-Japan Growth Story (3one4 Capital, June 2025)
- Pulse LinkedIn post on 3one4 Emergent Japan (LinkedIn, October 2026)
Related Reading
